The results demonstrated that HRAS, CXCL2, SLC38A1, PGD, ENPP2, ACSL3, DDIT4 and PSAT1 mRNA levels were upregulated in AML specimens, while PHKG2, HSD17B11, STEAP3 and ARNTL was downregulated (Figure S3). The gene discussed is HRAS; the disease is acute myeloid leukemia.